Gly-Sal 5-2 Pads

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Gly-Sal 5-2 Pads
Generic name: SALICYLIC ACID
Manufacturer: Topiderm, Inc.
Product type: HUMAN OTC DRUG
SPL set ID: e73bd26c-cdc2-47ab-94e8-3bc49a9b19e8
SPL ID: fbbae9e0-f0bf-4031-bc40-0b99bbe1e62d
Version: 5
Effective date: 2019-10-22
Source export date: 2026-10-12
Source partition: 5
Source file: https://download.open.fda.gov/drug/label/drug-label-0005-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/13cbfcd236c665f0ee69e2d9141331148dcdff45d1679c92f029cfba27dd74a2/drug-label-0005-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 01:43:52

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M006	openfda.application_number
brand name		Gly-Sal 5-2 Pads	openfda.brand_name
generic name		SALICYLIC ACID	openfda.generic_name
manufacturer name		Topiderm, Inc.	openfda.manufacturer_name
ndc	package	51326-038-60	openfda.package_ndc
ndc	product	51326-038	openfda.product_ndc
ndc11	package	51326003860	derived:openfda.package_ndc
rxcui		797892	openfda.rxcui
spl id		fbbae9e0-f0bf-4031-bc40-0b99bbe1e62d	id
spl set id		e73bd26c-cdc2-47ab-94e8-3bc49a9b19e8	set_id
unii		O414PZ4LPZ	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Keep away from eyes, lips, and mouth. If irritation develops, discontinue use and consult a doctor. Using other topical acne medication at the same time or immediately following use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor. Keep out of reach of children. If swallowed, seek professional assistance or contact a Poison Control Center immediately.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.